Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dec 1, 2025
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products (PDMPs) Across Europe
Against the backdrop of ongoing EU-level initiatives to improve the availability of critical medicines and strengthen supply chain resilience, this study aimed to map the overall PDMP policy landscape and key access dimensions, including reimbursement coverage, cost-containment measures, and stockpiling policies across Europe.
All
Publication
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/692dc8aeef30fe0ee32993ed_Understanding%20Reimbursement%20and%20Access%20Policies%20for%20Immunoglobulins%20Across%20Europe.pdf
Dec 1, 2025
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products (PDMPs) Across Europe
Against the backdrop of ongoing EU-level initiatives to improve the availability of critical medicines and strengthen supply chain resilience, this study aimed to map the overall PDMP policy landscape and key access dimensions, including reimbursement coverage, cost-containment measures, and stockpiling policies across Europe.
All
Publication
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/692dc8aeef30fe0ee32993ed_Understanding%20Reimbursement%20and%20Access%20Policies%20for%20Immunoglobulins%20Across%20Europe.pdf
Nov 19, 2025
PPTA Welcomes SFEE’s Position on Plasma-Derived Medicines for Greece
All
PPTA statements
Nov 19, 2025
PPTA Welcomes SFEE’s Position on Plasma-Derived Medicines for Greece
All
PPTA statements
No results found